Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00029003 | Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00075751 | Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 99 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00087412 | S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00777309 | A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 167 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 6 | Feb 28, 2013 | clinicaltrials |
| NCT00020709 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 840 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00021060 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 842 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00077350 | A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00824746 | Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)(ReGaiN) | completed | Phase 2 | 23 | Chonnam National University HospitalOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01139619 | A Retrospective Study to Investigate the Current Situation of Biopsy Testing in Swedish Inoperable Non Small Cell Lung Cancer (NSCLC) Patients(MAPSY) | completed | — | 136 | AstraZenecaINDUSTRY | 1 | Feb 25, 2013 | clinicaltrials |
| NCT00686465 | Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study(PETREC) | completed | N/A | 101 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT00457119 | Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients | completed | Phase 1 | 69 | Novartis PharmaceuticalsINDUSTRY | 3 | Feb 12, 2013 | clinicaltrials |
| NCT00265317 | A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone(SUN1058) | completed | Phase 2 | 162 | PfizerINDUSTRY | 8 | Feb 6, 2013 | clinicaltrials |
| NCT00280787 | Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim | completed | Phase 2 | 24 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00297089 | A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 165 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Jan 31, 2013 | clinicaltrials |
| NCT00622349 | Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer | completed | Phase 3 | 707 | European Lung Cancer Working PartyOTHER | 4 | Jan 30, 2013 | clinicaltrials |
| NCT00391248 | Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) | completed | Phase 2 | 40 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01099124 | Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC) | completed | N/A | 25 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01196234 | Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer(PRIDE) | completed | Phase 2 | 84 | Asan Medical CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00931008 | Study to Evaluate SID 530 Compared to Taxotere | completed | Phase 3 | 42 | SK Chemicals Co., Ltd.INDUSTRY | 2 | Jan 24, 2013 | clinicaltrials |
| NCT00005838 | Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 756 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00052338 | Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00960271 | Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)(EVIEPEB) | completed | — | 363 | University Hospital, RouenOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT01770795 | A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer | completed | Phase 2 | 45 | Gachon University Gil Medical CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00387374 | Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 0 | Jan 17, 2013 | clinicaltrials |
| NCT00004883 | Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 | completed | Phase 2 | 84 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01531790 | A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients | completed | Phase 1 | 19 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00136890 | PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers(ELPET) | completed | Phase 3 | 337 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jan 15, 2013 | clinicaltrials |
| NCT00068497 | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | N/A | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00063895 | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 9, 2013 | clinicaltrials |
| NCT00034879 | Iressa Expanded Access Program (EAP) | completed | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Jan 4, 2013 | clinicaltrials |
| NCT00050674 | Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma | completed | Phase 2 | 40 | Schwartzberg, Lee, M.D.INDIV | 1 | Dec 27, 2012 | clinicaltrials |
| NCT00379665 | Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy | completed | Phase 2 | 25 | Southwestern Regional Medical CenterOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00891579 | Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations | completed | Phase 2 | 161 | Chinese Society of Lung CancerOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00132665 | Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301) | completed | Phase 3 | 200 | Japan Clinical Oncology GroupOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT00173888 | Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer | completed | Phase 1 / Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 27, 2012 | clinicaltrials |
| NCT01466647 | A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) | completed | Phase 1 | 12 | Axelar ABINDUSTRY | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT01079520 | Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC) | completed | N/A | 138 | Samsung Medical CenterOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 26 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00840125 | Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment | completed | Phase 2 | 4 | Meir Medical CenterOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00702182 | Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer | completed | Phase 1 | 30 | National Cancer Centre, SingaporeOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01385111 | Combined Application of EBUS and EUS in Lung Cancer | completed | N/A | 162 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00095199 | Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | completed | Phase 3 | 939 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 15, 2012 | clinicaltrials |
| NCT00608868 | SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients(SELINE) | completed | Phase 4 | 156 | AstraZenecaINDUSTRY | 1 | Sep 28, 2012 | clinicaltrials |
| NCT01017133 | Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | completed | Phase 1 | 56 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 26, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Feb 28, 2013source: clinicaltrials